APA (7th ed.) Citation

Podar, K., Zimmerhackl, A., Fulciniti, M., Tonon, G., Hainz, U., Tai, Y., . . . Anderson, K. C. (2011). The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: Therapeutic implications. British journal of haematology, 155(4), . https://doi.org/10.1111/j.1365-2141.2011.08864.x

Chicago Style (17th ed.) Citation

Podar, Klaus, et al. "The Selective Adhesion Molecule Inhibitor Natalizumab Decreases Multiple Myeloma Cell Growth in the Bone Marrow Microenvironment: Therapeutic Implications." British Journal of Haematology 155, no. 4 (2011). https://doi.org/10.1111/j.1365-2141.2011.08864.x.

MLA (9th ed.) Citation

Podar, Klaus, et al. "The Selective Adhesion Molecule Inhibitor Natalizumab Decreases Multiple Myeloma Cell Growth in the Bone Marrow Microenvironment: Therapeutic Implications." British Journal of Haematology, vol. 155, no. 4, 2011, https://doi.org/10.1111/j.1365-2141.2011.08864.x.